Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Recruiting in Palo Alto (17 mi)

+3 other locations

Overseen by Neal J. Meropol, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 3

Waitlist Available

Sponsor: Case Comprehensive Cancer Center

No Placebo Group

Pivotal Trial (Near Approval)

Prior Safety Data

Trial Summary

What is the purpose of this trial?

RATIONALE: Providing information that is tailored to answer patients' questions about clinical trials may help patients with cancer decide to enroll in a clinical trial. It is not known whether providing personalized information is more effective than basic information in helping patients make decisions about clinical trials. PURPOSE: This randomized phase III trial is studying personalized information to see how well it works compared with basic information in helping patients make decisions about participating in a clinical trial.

Research Team

Neal J. Meropol, MD

Principal Investigator

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Eligibility Criteria

Inclusion Criteria

Advanced (metastatic) disease

Early stage (i.e., appropriate for adjuvant therapy) disease

Scheduled for first outpatient consultation with a medical oncologist at the Clinical Centers

Treatment Details

Interventions

• Educational Intervention (Behavioural Intervention)

Participant Groups

Group I: Arm I (PRE-ACT) Experimental Treatment 1 Intervention

Patients receive tailored feedback and video content to address clinical trial barriers following baseline assessment.

Group II: Arm II (control) Active Control 1 Intervention

Patients receive generic clinical trials educational feedback taken from NCI publications following baseline assessment.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, OH

Fox Chase Cancer Center - Philadelphia Philadelphia, PA

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, OH

Barbara Ann Karmanos Cancer Institute Detroit, MI

Who Is Running the Clinical Trial?

Case Comprehensive Cancer Center

Lead Sponsor

Trials

472

Patients Recruited

33,400+

National Cancer Institute (NCI)

Collaborator

Trials

14080

Patients Recruited

41,180,000+